HomeHome E-mail this pageE-mail this page Print this pagePrint this page
<img border="0" src="images/04subleft.gif" width="474" height="88" alt="The Mark of Individualized Medicine"> monogram biosciences
Individualized Medicine

Our Novel Technologies

Management

Scientific Advisory Board
Register for Updates
About Us
Management
Steven M. Anderson, PhD, received his BA in biology from St. Cloud State University and a PhD in genetics from Iowa State University. He has served in a variety of technical director positions for LabCorp during his 20-year tenure, including positions at the Center for Molecular Biology and Pathology (CMBP) and ViroMed Laboratories. Dr Anderson held the position of national director of research and development before assuming his current positions. He has published extensively in the areas of molecular diagnostics and has more than 140 published articles and abstracts in such areas as molecular genetics, molecular infectious disease, and cancer biomarkers.

Ken Hitchner, M.A., is General Manager of Monogram Biosciences as well as Vice President of Pharmaceutical Collaborations. He joined Monogram as Director of Project Management in May 1999 and was named Vice President of Pharmaceutical Collaborations in October 2003. Prior to Monogram, Ken was the Director of Project Management at Gilead Sciences. Ken was with Genentech for 15 years where he held a number of positions in Product Development and Quality Control. Ken received his bachelor's degree in zoology from DePauw University and a master's degree in biology from San Francisco State University.

Christos J. Petropoulos, PhD is Vice President of Research and Development and Chief Scientific Officer of Monogram Biosciences, as well as Vice President at LabCorp Inc. Dr. Petropoulos joined Monogram as Director of Research and Development in August 1996, became Senior Director of Research and Development in September 1997, was named Vice President, Research and Development in November 1999 and was named Vice President, Research and Development, Virology and Chief Scientific Officer in December 2004. In September 2010, Dr. Petropoulos assumed direct responsibility for Monogram’s Oncology R&D program in addition to the Virology R&D activities. From 1992 to 1996, Dr. Petropoulos was a scientist at Genentech where he headed the Molecular Virology Laboratory from 1992-1996 as well as the Research Virology and Molecular Detection Laboratories from 1994 to 1996. Dr. Petropoulos received his PhD in molecular and cell biology from Brown University and trained as a post-doctoral fellow at the National Cancer Institute’s Frederick Cancer Research and Development Center. Dr Petropoulos has co-authored over 120 scientific publications, is co-inventor on 20 issued patents and has been awarded 12 research grants from the National Institutes of Health.

Jeannette M. Whitcomb, PhD is Vice President of Operations at Monogram Biosciences, as well as Vice President at LabCorp Inc. She joined Monogram as one of the first scientists in the Research and Development department in 1996, transitioned to the Operations group in 2002 and was named Vice President of Operations in June 2003. Prior to joining Monogram, Dr. Whitcomb was a Postdoctoral Fellow at the National Cancer Institute-FCRDC and at the Swiss Institute for Experimental Cancer Research in Lausanne, Switzerland. Dr. Whitcomb received a BS in biology from Widener University and a PhD in microbiology and immunology from Temple University School of Medicine.

Contact Us | Site Map | Privacy Policy | Health Disclaimer | HIPAA Practice | Safe Harbor